Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0000950170-24-026641

SVP, Chief Accounting Officer sold 341 shares at $53.76 ($18,332)

  • SVP, Chief Accounting Officer gave up 121 shares (to pay taxes)
  • SVP, Chief Accounting Officer acquired 13,950 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Huizenga Theodore Alan · SVP, Chief Accounting Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-03-01 Grant or award : show line 1 in the form +13,950 41,842 D
2024-03-01 Shares withheld for taxes : show line 2 in the form −121 $53.69 $6,496 41,721 D
2024-03-01 Sale : show line 3 in the form −341 $53.76 $18,332 41,380 D
Open-market sales · 341 sh · avg $53.76 · $18,332

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-03-01 Grant or award : show line 4 in the form Stock Option (Right to Buy) +8,200 8,200 D
2024-03-01 Grant or award : show line 5 in the form Stock Option (Right to Buy) +2,351 2,351 D
Loading xslF345X05/ownership.xml…